lenalidomide
PolandDrugs containing this active substance
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Ltd.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH Synthon B.V. Synthon Hispania S.L.
-
The medicinal product is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Merckle GmbH, PLIVA Croatia Ltd., Teva Operations Poland Sp. z o.o.
-
The medicinal product is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Merckle GmbH, Pliva Croatia Ltd. (Pliva Hrvatska d.o.o.), Teva Operations Poland Sp. z o.o.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
Linorion is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Orion Corporation Orion Pharma, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The drug is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.